STAAR Surgical Company - ROE
STAA
Price:
$29.12
Market Cap:
$1.45B
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated in...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1992-02-24
Stock Exchange
NASDAQ
Ticker
STAA
PE Ratio
[-69.33]
ROE
[-6.07%]
Current Ratio
[5.12]
Dividend Yield
[0%]
Enterprise Value
[1.36B]
Dividend History
The ROE as of June 2026 (TTM) for STAAR Surgical Company (STAA) is -6.07%
According to STAAR Surgical Company’s latest financial reports and current stock price. The company's current ROE is -6.07%. This represents a change of 283.54% compared to the average of -1.58% of the last 4 quarters.
STAAR Surgical Company (STAA) Historical ROE (quarterly & annually)
How has STAA ROE performed in the past?
The mean historical ROE of STAAR Surgical Company over the last ten years is -2.19%. The current -6.07% ROE has changed 176.57% with respect to the historical average. Over the past ten years (40 quarters), STAA's ROE was at its highest in in the July 2022 quarter at 4.36%. The ROE was at its lowest in in the March 2025 quarter at -15.49%.
Average
-2.19%
Median
3.37%
Minimum
-32.00%
Maximum
11.80%
STAAR Surgical Company (STAA) ROE by Quarter and Year
Discovering the peaks and valleys of STAAR Surgical Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 359.58%
Maximum Annual ROE = 11.80%
Minimum Annual Increase = -191.95%
Minimum Annual ROE = -32.00%
| Year | ROE | Change |
|---|---|---|
| 2026 | -23.37% | 359.58% |
| 2024 | -5.09% | -191.95% |
| 2023 | 5.53% | -53.13% |
| 2022 | 11.80% | 10.91% |
| 2021 | 10.64% | 254.89% |
| 2021 | 3.00% | -65.88% |
| 2020 | 8.79% | 134.21% |
| 2018 | 3.75% | -175.30% |
| 2017 | -4.98% | -84.43% |
| 2016 | -32.00% | 90.27% |
STAAR Surgical Company (STAA) Average ROE
How has STAA ROE performed in the past?
The current ROE of STAAR Surgical Company (STAA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.64%
5-year avg
-0.10%
10-year avg
-2.19%
STAAR Surgical Company (STAA) ROE vs. Peers
How is STAA’s ROE compared to its peers?
STAAR Surgical Company’s ROE is greater than Kestra Medical Technologies, Ltd. (-68.83%), greater than Pulse Biosciences, Inc. (-86.67%), greater than NovoCure Limited (-50.82%), greater than Azenta, Inc. (-10.69%), greater than Beta Bionics, Inc. (-23.00%), greater than Tourmaline Bio, Inc. (-24.42%), greater than BioLife Solutions, Inc. (-2.91%), greater than Terns Pharmaceuticals, Inc. (-20.02%), greater than Precigen, Inc. (-1768.51%), greater than ORIC Pharmaceuticals, Inc. (-35.33%),
| Company | ROE | Market cap |
|---|---|---|
| -68.83% | $1.16B | |
| -86.67% | $1.77B | |
| -50.82% | $1.65B | |
| -10.69% | $1.07B | |
| -23.00% | $618.52M | |
| -24.42% | $1.23B | |
| -2.91% | $1.27B | |
| -20.02% | $4.77B | |
| -1768.51% | $1.45B | |
| -35.33% | $878.86M |
Build a custom stock screener for STAAR Surgical Company (STAA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like STAAR Surgical Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
STAAR Surgical Company (STAA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like STAAR Surgical Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is STAAR Surgical Company's ROE?
How is the ROE calculated for STAAR Surgical Company (STAA)?
What is the highest ROE for STAAR Surgical Company (STAA)?
What is the 3-year average ROE for STAAR Surgical Company (STAA)?
What is the 5-year average ROE for STAAR Surgical Company (STAA)?
How does the current ROE for STAAR Surgical Company (STAA) compare to its historical average?